Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is aimed to evaluate the effectiveness and safety of Jinlianqingre Effervescent Tablets, a traditional Chinese medicine (TCM), in the treatment of Uncomplicated hand, foot, and mouth disease (HFMD).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: China Academy of Chinese Medical Sciences
• Collaborators: Beijing Children's Hospital; Chengdu University of Traditional Chinese Medicine; Tangshan infectious disease hospital; The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine; Tianjin infectious disease hospital; Tianjin Zhongshenghaitian Pharmaceutical Co. Ltd.

Criteria

Inclusion Criteria:

• Clinical diagnosis of mild hand-foot-mouth disease patients according to Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of Health;

• Within 48 hours of onset of fever and rash symptom.

• Age of 1-13 years.

• Documented body temperature 37.4 °C-39.0°C

• Patients or their guardians agree to participate in this study and signed the informed consent form.

Exclusion Criteria:

• Complicated with other serious diseases such as chronic hepatitis,chronic diarrhea disease,chronic diarrhea, congenital heart disease, acute or chronic nephritis and blood diseases.

• With history of allergies on traditional Chinese medicine.

• Attending other clinical studies on HFMD after diagnosed.